论文部分内容阅读
目的:探讨苯磺酸左旋氨氯地平联合氯吡格雷治疗高血压合并冠心病的临床效果。方法:选择该院2014年01月至2015年6月收治的高血压病合并冠心病患者60例作为研究对象,随机分为对照组和观察组,各30例。对照组采用口服苯磺酸左旋氨氯地平治疗;观察组采用苯磺酸左旋氨氯地平联合氯吡格雷治疗,比较分析两组患者的疗效。结果:观察组治疗有效率明显高于对照组(P<0.05);观察组治疗后左心室射血分数显著优于对照组(P<0.05)。结论:相比于单纯苯磺酸左旋氨氯地平治疗,苯磺酸左旋氨氯地平联合氯吡格雷治疗高血压病合并冠心病能够显著提高疗效。
Objective: To investigate the clinical effect of levamlodipine besylate combined with clopidogrel in the treatment of hypertension and coronary heart disease. Methods: Sixty patients with hypertension complicated with coronary heart disease admitted to our hospital from January 2014 to June 2015 were selected as the research object and randomly divided into control group and observation group, with 30 cases in each group. The control group was treated with oral levamlodipine besylate. The observation group was treated with levamlodipine besylate combined with clopidogrel. The curative effect of the two groups was compared. Results: The effective rate of observation group was significantly higher than that of control group (P <0.05). Left ventricular ejection fraction of observation group was significantly better than that of control group (P <0.05). CONCLUSIONS: Compared with levamlodipine besylate alone, levamlodipine besylate combined with clopidogrel in the treatment of hypertension complicated with coronary heart disease can significantly improve the efficacy.